Findings from the current research have indicated that subsets of TILs, especially CD8+ T cell, are strongly associated with long-term oncological outcomes in patients with PDAC and limited CD8+ T cell infiltration is found in most PDAC tumor centers [33, 34]. Here, CD8A is linked to neoplasm.